South African AI Platform Leova Earns Global Acclaim for Accelerating Clinical Trial Prep

Johannesburg-based BioInformatiCo has achieved international recognition, placing second in the 2026 CDISC AI Innovation Challenge for its platform, Leova. This AI-powered tool is designed to significantly speed up the preparation of clinical trial databases, improve data quality, and optimize the use of limited funding for research teams globally. Leova automates critical aspects of building and testing digital databases used in trials for new medicines and vaccines, a process that traditionally consumes 10 to 20 weeks of specialist effort.

Leova's innovative approach streamlines the workflow by drafting data collection forms and validation rules from a study protocol, building the database, and then stress-testing it with simulated data. This allows researchers to identify errors and inconsistencies much earlier, reducing costly rework and accelerating trial readiness. The platform has already demonstrated its effectiveness, reducing database testing and validation time from five days to just one in a specific study, while maintaining stringent quality controls required in clinical research.

The global recognition comes at a crucial time for South Africa's medical research ecosystem, which is facing funding cuts and increased pressure. BioInformatiCo's founder, Shirley Collie, highlights that Leova not only addresses a worldwide bottleneck in clinical research but also strengthens Africa's capacity to generate evidence relevant to its own population's health needs. The company, which supports trials across sub-Saharan Africa, plans to expand internationally and open a seed funding round to further develop Leova and support its commercial growth.

This achievement underscores the potential of African-developed technology to make significant contributions to global health research. By improving efficiency and reducing costs in clinical trials, Leova can help ensure that new medicines and vaccines reach patients faster, while also empowering African research institutions to conduct more impactful studies despite resource constraints.